102 related articles for article (PubMed ID: 8180105)
1. The human estrogen receptor hormone binding domain dimerizes independently of ligand activation.
Salomonsson M; Häggblad J; O'Malley BW; Sitbon GM
J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):447-52. PubMed ID: 8180105
[TBL] [Abstract][Full Text] [Related]
2. Cooperativity and dimerization of recombinant human estrogen receptor hormone-binding domain.
Brandt ME; Vickery LE
J Biol Chem; 1997 Feb; 272(8):4843-9. PubMed ID: 9030541
[TBL] [Abstract][Full Text] [Related]
3. Generation of estrogen receptor mutants with altered ligand specificity for use in establishing a regulatable gene expression system.
Whelan J; Miller N
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):3-12. PubMed ID: 8809181
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
[TBL] [Abstract][Full Text] [Related]
5. The analysis of chimeric human/rainbow trout estrogen receptors reveals amino acid residues outside of P- and D-boxes important for the transactivation function.
Petit FG; Valotaire Y; Pakdel F
Nucleic Acids Res; 2000 Jul; 28(14):2634-42. PubMed ID: 10908317
[TBL] [Abstract][Full Text] [Related]
6. Function of estrogen receptor tyrosine 537 in hormone binding, DNA binding, and transactivation.
Yudt MR; Vorojeikina D; Zhong L; Skafar DF; Sasson S; Gasiewicz TA; Notides AC
Biochemistry; 1999 Oct; 38(43):14146-56. PubMed ID: 10571988
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of cysteine residues within the hormone-binding domain of the human estrogen receptor identifies mutants that are defective in both DNA-binding and subcellular distribution.
Neff S; Sadowski C; Miksicek RJ
Mol Endocrinol; 1994 Sep; 8(9):1215-23. PubMed ID: 7838154
[TBL] [Abstract][Full Text] [Related]
8. Altered ligand binding properties and enhanced stability of a constitutively active estrogen receptor: evidence that an open pocket conformation is required for ligand interaction.
Carlson KE; Choi I; Gee A; Katzenellenbogen BS; Katzenellenbogen JA
Biochemistry; 1997 Dec; 36(48):14897-905. PubMed ID: 9398213
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of the estrogen receptor ligand-binding domain: influence of ligand structure and stereochemistry on transactivation.
Kohno H; Bocchinfuso WP; Gandini O; Curtis SW; Korach KS
J Mol Endocrinol; 1996 Jun; 16(3):277-85. PubMed ID: 8782086
[TBL] [Abstract][Full Text] [Related]
10. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer.
Kumar V; Chambon P
Cell; 1988 Oct; 55(1):145-56. PubMed ID: 3167974
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of purified estradiol-liganded estrogen receptor by casein kinase II increases estrogen response element binding but does not alter ligand stability.
Tzeng DZ; Klinge CM
Biochem Biophys Res Commun; 1996 Jun; 223(3):554-60. PubMed ID: 8687434
[TBL] [Abstract][Full Text] [Related]
12. Structure-function analysis of the hormone binding domain of the human estrogen receptor by region-specific mutagenesis and phenotypic screening in yeast.
Wrenn CK; Katzenellenbogen BS
J Biol Chem; 1993 Nov; 268(32):24089-98. PubMed ID: 8226955
[TBL] [Abstract][Full Text] [Related]
13. Structural requirements for high affinity ligand binding by estrogen receptors: a comparative analysis of truncated and full length estrogen receptors expressed in bacteria, yeast, and mammalian cells.
Wooge CH; Nilsson GM; Heierson A; McDonnell DP; Katzenellenbogen BS
Mol Endocrinol; 1992 Jun; 6(6):861-9. PubMed ID: 1495491
[TBL] [Abstract][Full Text] [Related]
14. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
[TBL] [Abstract][Full Text] [Related]
15. Activation of estrogen receptor-alpha by the heavy metal cadmium.
Stoica A; Katzenellenbogen BS; Martin MB
Mol Endocrinol; 2000 Apr; 14(4):545-53. PubMed ID: 10770491
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of the human estrogen receptor in yeast.
White JH; Metzger D; Chambon P
Cold Spring Harb Symp Quant Biol; 1988; 53 Pt 2():819-28. PubMed ID: 3076099
[No Abstract] [Full Text] [Related]
17. Cross-linking of estrogen receptor to chromatin in intact MCF-7 human breast cancer cells: optimization and effect of ligand.
Wrenn CK; Katzenellenbogen BS
Mol Endocrinol; 1990 Nov; 4(11):1647-54. PubMed ID: 2280770
[TBL] [Abstract][Full Text] [Related]
18. Kinetic analysis of the interaction of human estrogen receptor with an estrogen response element.
Melamed M; Arnold SF; Notides AC; Sasson S
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):153-9. PubMed ID: 8645623
[TBL] [Abstract][Full Text] [Related]
19. Calmodulin decreases the estrogen binding capacity of the estrogen receptor.
Bouhoute A; Leclercq G
Biochem Biophys Res Commun; 1996 Oct; 227(3):651-7. PubMed ID: 8885989
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain.
Beekman JM; Allan GF; Tsai SY; Tsai MJ; O'Malley BW
Mol Endocrinol; 1993 Oct; 7(10):1266-74. PubMed ID: 8264659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
